CA 19-9, CA 125, CEA, GLUCOSE, INSULIN AND ACTH LEVELS IN PATIENTS WITH GASTRIC CANCER

Basit Öğe Kaydı
dc.contributor.authorİRAK, Kıvanç
dc.contributor.authorMERT, Handan
dc.contributor.authorDOĞAN SÖĞÜTLÜ, İnci
dc.contributor.authorMERT, Nihat
dc.date.accessioned2017-04-28T06:50:43Z
dc.date.available2017-04-28T06:50:43Z
dc.date.issued2016
dc.departmentBelirleneceken_US
dc.description.abstractGastric tumor remains a major health hazard during the decades. Generally it is the third most common cases and has high mortality rates. In the presented study it was aimed to investigate the serum levels of CA 19-9, CA 125, CEA, insulin, glucose and ACTH in patients with gastric cancer. The blood samples of 22 male (45-74 ages old), 12 female (50-75 years old) and 15 healthy subjects were taken before the breakfast and sera were seperated and all analyzed were done immediately. The CA 19-9, CA 125, CEA levels were found in healthy and patients with gastric cancer as 2.09-17.32 ng/ml, 6.94-63.21 U/ml, 9.31-49.71 U/ml respectively. The differences between the groups of these three parameters were statistically significant (p?0.01). The fasting blood glucose and insulin amount were found in normal and cancer cases as, 83.14- 98.33mg/dl (p?0.05), 10.22-8.17 µU/ml (p?0.05) respectively. ACTH levels were slightly higher in cancer patients compared with controls 58.31- 44.28 pg/ml (p?0.05). Tumor markers were increased in all patients with gastric cancer. Some of the patients had diabetic pattern but blood glucose levels over 120 mg/dl were only documented in 8 cases. The results were evaluated clinic pathologically. As conclusion all analyzed parameters were changed in gastric cancer cases. Insulin and ACTH hormones can be properly assessed during the various stages of cancer. As far, we can still use CA 19-9, CA 125, CEA as a reliable tumor markers in gastric cancer.en_US
dc.identifier.urihttps://hdl.handle.net/20.500.12604/412
dc.language.isotren_US
dc.relation.publicationcategoryUluslararası Hakemli Dergi Makalesien_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.snmz#KayıtKontrol#
dc.subjectACTH, CA 19-9, CA 125, CEA, Gastric cancer, Glucose, Insulinen_US
dc.titleCA 19-9, CA 125, CEA, GLUCOSE, INSULIN AND ACTH LEVELS IN PATIENTS WITH GASTRIC CANCERen_US
dc.title.alternativeIRAK K1; MERT H2; SOGUTLU I D3; MERT Nen_US
dc.typeArticleen_US

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
Küçük Resim
İsim:
CA 19-9, CA 125, CEA, GLUCOSE, INSULIN AND ACTH LEVELS IN PATIENTS.pdf
Boyut:
280.82 KB
Biçim:
Adobe Portable Document Format
Açıklama:
CA 19-9, CA 125, CEA, GLUCOSE, INSULIN AND ACTH LEVELS IN PATIENTS WITH GASTRIC CANCER
İndir
Lisans paketi
Listeleniyor 1 - 1 / 1
[ X ]
İsim:
license.txt
Boyut:
1.71 KB
Biçim:
Item-specific license agreed upon to submission
Açıklama:
İndir

Koleksiyon

2) Makale